Disc Medicine (IRON) Treasury Shares (2020 - 2025)
Disc Medicine (IRON) reported Treasury Shares of $1.1 million for Q4 2025, up 140.44% year-over-year from $475140.0 in Q4 2024, and up 140.44% on a QoQ basis from $475140.0 in Q4 2024.
Disc Medicine (IRON) has 6 years of Treasury Shares data on file, last reported at $1.1 million in Q4 2025.
- Quarterly Treasury Shares rose 140.44% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (up 140.44% YoY) and the FY2025 annual result came in at $1.1 million, up 140.44% from the prior year.
- Treasury Shares climbed to $1.1 million in Q4 2025 per IRON's latest filing, from $475140.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.1 million in Q4 2025 and bottomed at $958.0 in Q1 2023.
- The 5-year median for Treasury Shares is $7885.0 (2022), against an average of $230772.4.
- The widest annual swing landed in 2023, when Treasury Shares tumbled 87.85%; it then soared 140.44% in 2025.
- Tracing IRON's Treasury Shares over 5 years: stood at $10170.0 in 2021, then sank by 81.16% to $1916.0 in 2022, then tumbled by 50.0% to $958.0 in 2023, then jumped by 49497.08% to $475140.0 in 2024, then surged by 140.44% to $1.1 million in 2025.
- Per Business Quant, the three latest IRON Treasury Shares figures stand at $1.1 million (Q4 2025), $475140.0 (Q4 2024), and $429522.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 475,140.00 |
| Dec 31, 2024 | 475,140.00 |
| Sep 30, 2024 | 429,522.00 |
| Sep 30, 2024 | 429,522.00 |
| Mar 31, 2023 | 958.00 |
| Mar 31, 2023 | 958.00 |
| Dec 31, 2022 | 1,916.00 |
| Dec 31, 2022 | 1,916.00 |
| Sep 30, 2022 | 3,316.00 |
| Sep 30, 2022 | 3,316.00 |
| Jun 30, 2022 | 5,600.00 |
| Jun 30, 2022 | 5,600.00 |
| Mar 31, 2022 | 7,885.00 |
| Mar 31, 2022 | 7,885.00 |
| Dec 31, 2021 | 10,170.00 |
| Dec 31, 2021 | 10,170.00 |
| Dec 31, 2020 | 24,940.00 |
| Dec 31, 2020 | 24,940.00 |